The Utility of Macrolide Therapy for Neutrophilic CRSsNP Based on Structured Histopathology. [PDF]
Yu AJ +9 more
europepmc +1 more source
Host inflammatory markers and MLVA profiling for risk assessment of severe pediatric <i>Mycoplasma pneumoniae</i> pneumonia. [PDF]
Xu H +10 more
europepmc +1 more source
Radiographic severity and treatment optimisation in <i>Mycobacterium avium</i> complex pulmonary disease. [PDF]
Cho Y +5 more
europepmc +1 more source
Macrolide Resistance of <i>Mycoplasma pneumoniae</i> Among Children in Hangzhou: A 2024-2025 Post-Pandemic Surveillance Study. [PDF]
Xu X, Xiao X, Zhou J, Zhao X.
europepmc +1 more source
East Asia as a sentinel: risk-stratified corticosteroid therapy for paediatric macrolide-resistant <i>Mycoplasma pneumoniae</i> pneumonia. [PDF]
Huang YS, Kuo KC, Su YT, Yu HR.
europepmc +1 more source
Molecular Mechanisms Underlying Antimicrobial Resistance in Mycobacteria. [PDF]
López-Roa P, Esteban J, Muñoz-Egea MC.
europepmc +1 more source
Longitudinal Breath Sound Changes During Erythromycin Therapy in Paediatric Diffuse Panbronchiolitis. [PDF]
Iikura K +5 more
europepmc +1 more source
Detection of Pasteurella multocida and macrolide resistance genes in calf pneumonia: an immunohistochemical and molecular approach. [PDF]
Ates MB +6 more
europepmc +1 more source
Post-pandemic surge of <i>Mycoplasma pneumoniae</i> in Ontario, 2024: molecular surveillance and resistance trends relative to 2018-2023. [PDF]
McTaggart LR +4 more
europepmc +1 more source
Construction of a nomogram combining CT and serum markers for predicting macrolide resistance gene mutation status in pediatric Mycoplasma pneumoniae pneumonia. [PDF]
Yuan X +5 more
europepmc +1 more source

